There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Sonendo (SONX – Research Report), Rani Therapeutics Holdings (RANI – Research Report) and Valneva (VALN – Research Report) with bullish sentiments.
Sonendo (SONX)
Bank of America Securities analyst Allen Lutz reiterated a Buy rating on Sonendo today and set a price target of $1.00. The company’s shares closed last Wednesday at $0.24, close to its 52-week low of $0.22.
According to TipRanks.com, Lutz is a 2-star analyst with an average return of
Currently, the analyst consensus on Sonendo is a Moderate Buy with an average price target of $1.25.
See today’s best-performing stocks on TipRanks >>
Rani Therapeutics Holdings (RANI)
In a report released today, Mitchell Kapoor from H.C. Wainwright reiterated a Buy rating on Rani Therapeutics Holdings, with a price target of $20.00. The company’s shares closed last Wednesday at $1.98, close to its 52-week low of $1.85.
According to TipRanks.com, Kapoor is ranked 0 out of 5 stars with an average return of
Rani Therapeutics Holdings has an analyst consensus of Strong Buy, with a price target consensus of $20.25.
Valneva (VALN)
H.C. Wainwright analyst Edward White reiterated a Buy rating on Valneva today and set a price target of $22.00. The company’s shares closed last Wednesday at $11.60.
According to TipRanks.com, White ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Valneva has an analyst consensus of Moderate Buy, with a price target consensus of $22.00.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on SONX:
